Figure 4

Overview of the site-specific N-glycan distribution of neuraminidase from the candidate vaccine of NIBRG-121xp. The N-glycosylation microheterogenetity at the individual sites of the protein sequence chain is shown.
Overview of the site-specific N-glycan distribution of neuraminidase from the candidate vaccine of NIBRG-121xp. The N-glycosylation microheterogenetity at the individual sites of the protein sequence chain is shown.